US2003175694A1PendingUtilityA1
Method for determining biological agents in living target cells
Priority: May 9, 2000Filed: May 4, 2001Published: Sep 18, 2003
Est. expiryMay 9, 2020(expired)· nominal 20-yr term from priority
Inventors:Manuel Vega
G01N 33/5005Y02A90/10
45
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Method for determining the titer (concentration) of biological agents, such as viral vectors for gene transfer, in real time, in living target cells and uses thereof in the field of gene therapy and diagnosis.
Claims
exact text as granted — not AI-modified1 °) Method for determining the titer of a biologic agent interacting with living target cells, characterized in that it comprises at least the following steps:
(a 1 ) the incubation of said biological agent at unknown initial concentration C, with said target cells at constant concentration D,
(b 1 ) the measurement at various successive times t of the intensity i of the same signal, which results from the reaction biological agent+living target cells,
(c 1 ) the determination of the time t β corresponding to the i=β value, chosen in the interval β min <β<β max , such as β min and β max correspond to the values of i at the inflexion point of the i=f(t) curve for respectively the minimal and maximal concentrations of a standard biological agent, for which the t β =f(C) curve is pre-established, and
(d 1 ) the determination of the initial concentration C of the biologic agent, with the help of said t β =f(C) standard curve.
2 °) Method according to claim 1 , characterized in that, simultaneously or before the step (a 1 ), said standard curve is established according to the following steps:
(a 0 ) the preparation of n serial dilutions of a standard biological agent at a known initial concentration C 0 , corresponding to said biological agent final concentrations C 1 , C 2 , . . . C n , respectively,
(b 0 ) the incubation of each standard biological agent dilution obtained in (a 0 ), with said target cells at a constant concentration D,
(c 0 ) the determination of the signal intensity i which results from the reaction biological agent+living target cells, for each standard biological agent concentration C 1 , C 2 , . . . C n ′ at various successive times t 1 to t n ′
(d 0 ) the drawing of the i=f(t) curve for each value of C 1 , C 2 , . . . C n ′
(e 0 ) the determination of the B value of i, such that β min <β<B max and B min and B max correspond to the values of i at the inflexion point of the i=f(t) curve for C n and C 1 , respectively, and
(f 0 ) the drawing of the t β =f (C) standard curve for the i=β value.
3 °) Method according to claim 1 or claim 2 , characterized in that said biological agent is selected from the group consisting of viruses, viral and non-viral vectors for genes transfer, vaccines, antibodies and recombinant proteins.
4 °) Method according to anyone of claims 1 to 3 , characterized in that said signal is selected from the group consisting of fluorescence, luminescence, absorbance and cell numeration.
5 °) Kit for the quantification or the detection of a biological agent, characterized in that it comprises:
living target cells at a constant concentration D,
a standard biological agent at known concentration C, and
the t β =f(C)standard curve of said standard biological agent.Join the waitlist — get patent alerts
Track US2003175694A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.